Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine administered according to 2- and 3-dose schedules in girls aged 9–14 years: Results to month 12 from a randomized trial
Leung, Ting Fan, Liu, Anthony Pak-Yin, Lim, Fong Seng, Thollot, Franck, Oh, Helen May Lin, Lee, Bee Wah, Rombo, Lars, Tan, Ngiap Chuan, Rouzier, Roman, Friel, Damien, De Muynck, Benoit, De Simoni, StéVolume:
11
Language:
english
Journal:
Human Vaccines & Immunotherapeutics
DOI:
10.1080/21645515.2015.1050570
Date:
July, 2015
File:
PDF, 890 KB
english, 2015
File converter
More search results
More benefits 
